Capula Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-250
Closed -$73.2K 840
2026
Q1
$73.2K Buy
+250
New +$82.2K ﹤0.01% 946
2025
Q4
Sell
-63
Closed -$21.3K 853
2025
Q3
$20.4K Sell
63
-186
-75% -$57.8K ﹤0.01% 781
2025
Q2
$96.9K Sell
249
-75
-23% -$30.2K ﹤0.01% 507
2025
Q1
$141K Buy
+324
New +$130K ﹤0.01% 585
2024
Q2
Sell
-1,135
Closed -$589K 500
2024
Q1
$589K Buy
1,135
+234
+26% +$116K 0.01% 178
2023
Q4
$425K Sell
901
-219
-20% -$101K 0.02% 168
2023
Q3
$488K Buy
+1,120
New +$508K 0.01% 349
2023
Q2
Sell
-466
Closed -$214K 537
2023
Q1
$214K Sell
466
-4,262
-90% -$2.03M ﹤0.01% 597
2022
Q4
$2.43M Buy
+4,728
New +$2.4M 0.03% 326
2022
Q3
Sell
-1,685
Closed -$813K 610
2022
Q2
$813K Buy
+1,685
New +$834K 0.01% 276
2021
Q4
Sell
-4,826
Closed -$1.8M 387
2021
Q3
$1.8M Buy
4,826
+182
+4% +$69.2K 0.02% 423
2021
Q2
$1.77M Buy
4,644
+3,562
+329% +$1.36M 0.03% 310
2021
Q1
$388K Buy
1,082
+199
+23% +$64K 0.01% 405
2020
Q4
$284K Buy
+883
New +$271K 0.01% 256

Other funds holding ELV

Capula Management's ELV Position: Q2 2026 in Review

Capula Management sold out of Elevance Health (ELV) in Q2 2026, closing a stake of 250 shares — an estimated $73.2K sold.

Capula Management first reported a position in ELV in Q4 2020 and held it in 14 quarters. The position peaked at $2.43M in Q4 2022. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Capula Management reported no remaining Elevance Health position as of Q2 2026 after selling out during the quarter.
  • Capula Management sold 250 Elevance Health shares in Q2 2026, an estimated $73.2K.
  • Capula Management first reported a position in Elevance Health in Q4 2020 and held it in 14 quarters.
  • Capula Management's Elevance Health position peaked at $2.43M in Q4 2022.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Capula Management's 13F filing for Q2 2026, filed 14 Aug 2026.